EZH2 Represses Target Genes through H3K27-Dependent and H3K27-Independent Mechanisms in Hepatocellular Carcinoma
Shu-Bin Gao(Xiamen University), Guang‐Hui Jin(Xiamen University), Kang‐Li Li(Guangdong-Hongkong-Macau Joint Laboratory of Collaborative Innovation for Environmental Quality), Yue Zhao(Zhejiang Cancer Hospital), Bin Xu(Xiamen University), Qi‐Fan Zheng(Xiamen University), Qilin Zheng(Xiamen University), Xiao Lin(Xiamen University), Chang-Bao Pan(Xiamen University), Lixiang Xue(Peking University)
Cited by 69
Related Papers
IL-7: A promising adjuvant ensuring effective T cell responses and memory in combination with cancer vaccines?
|Frontiers in Immunology|2022|72
Chromosome-Scale Assembly of the Dendrobium nobile Genome Provides Insights Into the Molecular Mechanism of the Biosynthesis of the Medicinal Active Ingredient of Dendrobium
|Frontiers in Genetics|2022|61
Dysregulated lipid metabolism blunts the sensitivity of cancer cells to EZH2 inhibitor
|EBioMedicine|2022|42
Genome-wide identification of the alkaloid synthesis gene family CYP450, gives new insights into alkaloid resource utilization in medicinal Dendrobium
|International Journal of Biological Macromolecules|2024|17